Helicobacter pylori eradication in children and adolescents by a once daily 6-day treatment with or without a proton pump inhibitor in a double-blind randomized trial

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 3, 2004, Pages 295-302

  Tindberg, Y ^a   Casswall, T H ^b   Blennow, M ^c   Bengtsson, C ^d   Granstrom M ^d   Sorberg M ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; LANSOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; TINIDAZOLE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG ERUPTION; DYSGEUSIA; ERADICATION THERAPY; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME; UREA BREATH TEST; VOMITING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AZITHROMYCIN; BREATH TESTS; CHILD; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; OMEPRAZOLE; PATIENT COMPLIANCE; PROTON PUMPS; TINIDAZOLE; TREATMENT OUTCOME;

EID: 4043124667     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02077.x     Document Type: Article

References (35)

1. NIH Consensus Statement. Helicobacter pylori in Peptic Ulcer Disease; 1994 February 7-9.
2. Ekström AM, Held M, Hansson LE, Engstrand L, Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121: 784-91.
3. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
4. Blaser MJ, Chyou PH, Normura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res 1995; 55: 562-5.
5. Gottrand F, Kalach N, Spyckerelle C, et al. Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: a prospective randomized double-blind trial. J Pediatr 2001; 139: 664-8.
6. Oderda G, Rapa A, Bona G. A systematic review of Helicobacter pylori eradication treatment schedules in children. Aliment Pharmacol Ther 2000; 14(Suppl. 3): 59-66.
7. Sherman P, Hassall E, Hunt RH, Fallone CA, van Zanten SV, Thomson ABR. Canadian Helicobacter Study Group consensus conference on the approach to Helicobacter pylori infection in children and adolescents. Can J Gastroenterol 1999; 13: 553-9.
8. Gold BD, Colletti RB, Abbott M, et al. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000; 31: 490-7.
9. Drumm B, Koletzko S. Oderda G on behalf of the European Paediatric Task Force on Helicobacter pylori. Helicobacter pylori infection in children: a consensus statement. J Pediatr Gastroenterol Nutr 2000; 30: 207-13.
10. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2. 2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-80.
11. Tindberg Y, Bengtsson C, Granath F, Blennow M, Nyrén O. Granström M. Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology 2001; 121: 310-6.
12. Tindberg Y, Bengtsson C, Bergström M, Granström M. The accuracy of serologic diagnosis of Helicobacter pylori infection in school-aged children of mixed ethnicity. Helicobacter 2001; 6: 24-30.
13. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6: 209-22.
14. Blandizzi C, Malizia T, Gherardi G, et al. Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis. J Antimicrob Chemother 1998; 42: 75-82.
15. Krichhoff RM, Laufen H, Schacke G, Kirchhoff G, Gallo E. Determination of azithromycin in gastric biopsy samples. Int J Clin Pharmacol Ther 1999; 37: 361-4.
16. Caselli M, Ruina M, Fabbri P, Balhous W, Alvisi V. A comparative trial of short term therapy with omeprazole plus either amoxycillin or azithromycin for Helicobacter pylori eradication. J Antimicrob Chemother 1996; 37: 849-50.
17. Bertoni G, Sassatelli R, Nigrisoli E, et al. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol 1996; 91: 258-63.
18. Calabrese C, Di Febo G, Areni A, Scialpi C, Biasco G, Miglioli M. Pantoprazole, azitromycin and tinidazole: short triple therapy for eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14: 1613-17.
19. Cammarota G, Tursi A, Papa A, et al. Helicobcter pylori eradication using one-week low-dose lanzoprazole plus amoxicillin and either clarithromycin or azithromycin. Aliment Pharmacol Ther 1996; 10: 997-1000.
20. Sullivan B, Coyle W, Nemec R, Dunteman T. Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. Am J Gastroenterol 2002; 97: 2536-9.
21. Chey WD, Fischer L, Barnett J, et al. Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998; 12: 1263-67.
22. Dalla Libera M, Pazzi P, Carli G, et al. High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication. Aliment Pharmacol Ther 1996; 10: 203-6.
23. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week tripple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835-40.
24. Malizia T, Tejada M, Marchetti F, et al. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study. J Antimicrob Chemother 1998; 41(Suppl. B): 29-35.
25. Oderda G, Vaira D, Ainley C, et al. Eighteen month follow up of Helicobacter pylori positive children treated with amoxicilin and tinidazole. Gut 1992; 33: 1328-30.
26. Behrens R, Lang T, Keller KM, et al. Dual versus triple therapy of Helicobacter pylori infection: results of a multicentre trial. Arch Dis Child 1999; 81: 68-70.
27. Fiese EF, Steffen SH. Comparison of the acid stability of azithromycin and erythromycin A. J Antimicrob Chemother 1990; 25(Suppl. A): 39-47.
28. Casswall TH, Alfvén G, Drapinski M, Bergström M, Dahlström KA. One-week treatment with omeprazole, chlarithromycin, and metronidazole in children with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr 1998; 27: 415-8.
29. Wheeldon TU, Hoang TT, Phung DC, Bjorkman A, Granstrom M, Sorberg M, Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment. Aliment Pharmacol Ther 2003; 18: 93-100.
30. Vallve M, Vergara M, Gisbert JP, Calvet X. Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. Aliment Pharmacol Ther 2002; 16: 1149-56.
31. Dupont C, Kalach N, Raymond J. Helicobacter pylori and antimicrobial susceptibility in children. J Pediatr Gastroenterol Nutr 2003; 36: 311-3.
32. Crone J, Granditsch G, Huber WD, et al. Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000. J Pediatr Gastroenterol Nutr 2003; 36: 368-71.
33. Asaka M, Kudo M, Kato M, Sugiyama T, Takeda H. Review article: Long-term Helicobacter pylori infection - from gastritis to gastric cancer. Aliment Pharmacol Ther 1998; 12(Suppl. 1): 9-15.
34. Jones NL, Sherman PM. Helicobacter pylori infection in children. Curr Opin Pediatr 1998; 10: 19-23.
35. Gisbert JP, Marcos S, Gisbert JL, Pajares JM. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. Eur J Gastroenterol Hepatol 2001; 13: 1303-7.